Intelligent Bio Solutions (INBS) Net Cash Flow (2020 - 2024)
Intelligent Bio Solutions has reported Net Cash Flow over the past 5 years, most recently at $8.3 million for Q1 2024.
- Quarterly results put Net Cash Flow at $8.3 million for Q1 2024, up 1427.71% from a year ago — trailing twelve months through Mar 2024 was $3.4 million (up 142.73% YoY), and the annual figure for FY2023 was -$6.6 million, down 56.58%.
- Net Cash Flow for Q1 2024 was $8.3 million at Intelligent Bio Solutions, up from -$2.9 million in the prior quarter.
- Over the last five years, Net Cash Flow for INBS hit a ceiling of $18.8 million in Q4 2020 and a floor of -$5.7 million in Q1 2021.
- Median Net Cash Flow over the past 5 years was -$719978.0 (2023), compared with a mean of $356442.6.
- Biggest five-year swings in Net Cash Flow: crashed 2955.07% in 2022 and later surged 1427.71% in 2024.
- Intelligent Bio Solutions' Net Cash Flow stood at $18.8 million in 2020, then tumbled by 107.57% to -$1.4 million in 2021, then tumbled by 81.83% to -$2.6 million in 2022, then dropped by 10.69% to -$2.9 million in 2023, then soared by 390.16% to $8.3 million in 2024.
- The last three reported values for Net Cash Flow were $8.3 million (Q1 2024), -$2.9 million (Q4 2023), and -$1.3 million (Q3 2023) per Business Quant data.